ACTIVE

DR. THOMAS GILISSEN

Financial year 2025 · Closed on 31/12/2025

Net result157,3 k €-15,3 %over 1 year
Gross margin274,2 k €-8,4 %over 1 year
Equity516,8 k €+3,5 %over 1 year
Workforce0,0 ETP

Identity

Source · BCE/KBO

DR. THOMAS GILISSEN is a Private limited company incorporated in 2022. Its main activity is: General medical practice activities. Its registered office is in Riemst.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0782.969.350
Incorporation
08/03/2022
Legal form
Private limited company
Registered office
Demerstraat 54
3770 Riemst · FlandreSee on map
Contributed capital
5 000,00 €
Latest accounts
31/12/2025
Average workforce
0,0 ETP
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 4 filings

Trend over 4 financial years

2025202420232022
Income statement
Gross margin274,2 k €299,3 k €259,7 k €201,7 k €
EBITDA273,7 k €284,2 k €254,5 k €201,2 k €
Operating result225,3 k €264,7 k €240,2 k €187,9 k €
Net result157,3 k €185,9 k €167,9 k €140,7 k €
Balance sheet
Equity516,8 k €499,5 k €313,6 k €145,7 k €
Total assets807,2 k €739,6 k €402,7 k €195,9 k €
Cash69,2 k €88,3 k €304,7 k €147,5 k €
Debts287,3 k €239,2 k €89,1 k €50,1 k €
Other
Workforce0,0 ETP0,0 ETP––

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

Thomas GILISSEN

Director

Active

Other companies at this address

Demerstraat 54 3770 Riemst
CompanyCBE no.
LAPITO● Active
0782.967.568

Full financial information

Source · NBB
2025202420232022
Type of accountAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202307/03/2022
Closing of the financial year31/12/202531/12/202431/12/202331/12/2022
Length of the financial year12 months12 months12 months10 months
Filing date09/03/202609/07/202525/09/202419/09/2023
General meeting12/02/202625/06/202525/06/202425/06/2023
Currency of the financial yearEUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 4 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202512/02/202609/03/2026DutchPDF
Abridged model31/12/202425/06/202509/07/2025DutchPDF
Abridged model31/12/202325/06/202425/09/2024DutchPDF
Abridged model31/12/202225/06/202319/09/2023DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

Thomas GILISSEN

Director

Active

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other10/03/2022
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025157,3 k €↓
  2. 2024
    Annual accounts 2024185,9 k €↑
  3. 2023
    Annual accounts 2023167,9 k €↑
  4. 2022
    Annual accounts 2022140,7 k €
  5. 08/03/2022
    IncorporationPrivate limited company